Cargando…

P19-47. Novel adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity

Detalles Bibliográficos
Autores principales:	Gabitzsch, ES, Xu, Y, Yoshida, LH, Balint, JP, Amalfitano, A, Jones, FR
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767878/ http://dx.doi.org/10.1186/1742-4690-6-S3-P367

Ejemplares similares

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses
por: Hopkins, Kathryn L., et al.
Publicado: (2014)

Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag–pol–nef antigen
por: Herath, S., et al.
Publicado: (2015)

HLA-Associated Immune Escape Pathways in HIV-1 Subtype B Gag, Pol and Nef Proteins
por: Brumme, Zabrina L., et al.
Publicado: (2009)

Immunogenicity when utilizing adenovirus serotype 4 and 5 vaccines expressing circumsporozoite protein in naïve and Adenovirus (Ad5) immune mice
por: Schuldt, Nathaniel J, et al.
Publicado: (2012)

An Ad5 [E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice
por: Gabitzsch, Elizabeth S., et al.
Publicado: (2011)

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults
por: Omosa-Manyonyi, Gloria, et al.
Publicado: (2015)

P19-32. HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses
por: Wild, J, et al.
Publicado: (2009)

MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load
por: Janes, Holly, et al.
Publicado: (2012)

FRET analysis of HIV‐1 Gag and GagPol interactions
por: Takagi, Shimon, et al.
Publicado: (2017)

P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial
por: Fellay, J, et al.
Publicado: (2009)

Modulation of HIV-1 Gag/Gag-Pol frameshifting by tRNA abundance
por: Korniy, Natalia, et al.
Publicado: (2019)

Effects of reduced gag cleavage efficiency on HIV-1 Gag-Pol package
por: Lin, Yi-Ru, et al.
Publicado: (2022)

Adenovirus-Specific Immunity Following Immunization with an Ad5 HIV-1 Vaccine Candidate in Humans
por: O’Brien, Kara L., et al.
Publicado: (2009)

HIV Pol Inhibits HIV Budding and Mediates the Severe Budding Defect of Gag-Pol
por: Gan, Xin, et al.
Publicado: (2012)

Improving Adenovirus Based Gene Transfer: Strategies to Accomplish Immune Evasion
por: Seregin, Sergey S., et al.
Publicado: (2010)

An Essential Role of INI1/hSNF5 Chromatin Remodeling Protein in HIV-1 Posttranscriptional Events and Gag/Gag-Pol Stability
por: La Porte, Annalena, et al.
Publicado: (2016)

Novel adenoviral serotype 5 based immunotherapeutic induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
por: Morse, Michael, et al.
Publicado: (2013)

A Rev-Independent gag/pol Eliminates Detectable psi-gag Recombination in Lentiviral Vectors
por: Tareen, Semih U., et al.
Publicado: (2013)

Immune Recognition of Gene Transfer Vectors: Focus on Adenovirus as a Paradigm
por: Aldhamen, Yasser Ali, et al.
Publicado: (2011)

A purine-rich element in foamy virus pol regulates env splicing and gag/pol expression
por: Moschall, Rebecca, et al.
Publicado: (2017)

Enhancement of ribosomal frameshifting by oligonucleotides targeted to the HIV gag-pol region.
por: Vickers, T A, et al.
Publicado: (1992)

Determination of the relative amounts of Gag and Pol proteins in foamy virus particles
por: Cartellieri, Marc, et al.
Publicado: (2005)

Signals for ribosomal frameshifting in the rous sarcoma virus gag-pol region
por: Jacks, Tyler, et al.
Publicado: (1988)

Potent Nonnucleoside Reverse Transcriptase Inhibitors Target HIV-1 Gag-Pol
por: Figueiredo, Anna, et al.
Publicado: (2006)

Control of gag-pol gene expression in the Candida albicans retrotransposon Tca2
por: Forbes, Elaine M, et al.
Publicado: (2007)

Identification and analysis of the gag-pol ribosomal frameshift site of feline immunodeficiency virus
por: Morikawa, Shigeru, et al.
Publicado: (1992)

HIV-1 Mutant Assembly, Processing and Infectivity Expresses Pol Independent of Gag
por: Yu, Fu-Hsien, et al.
Publicado: (2020)

Stimulation of antiviral cellular immune responses by therapeutic vaccination of HIV-1-infected patients with dendritic cells transfected with gag, tat, rev and nef mRNA
por: Van Gulck, Ellen, et al.
Publicado: (2011)

HIV-1 Nef promotes the localization of Gag to the cell membrane and facilitates viral cell-to-cell transfer
por: Malbec, Marine, et al.
Publicado: (2013)

Orthoretroviral-like prototype foamy virus gag-pol expression is compatible with viral replication
por: Swiersy, Anka, et al.
Publicado: (2011)

Expression of Gag and Pol from reconstructed HERV-Fc1, associated with multiple sclerosis
por: Nissen, Kari K, et al.
Publicado: (2011)

Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity
por: Flickinger Jr, John C, et al.
Publicado: (2020)

Different memory T cell phenotypes are elicited by Ad5 and rare adenoviruses
por: Penaloza, P, et al.
Publicado: (2012)

Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures
por: Stepanenko, Aleksei A., et al.
Publicado: (2021)

GagPol-specific CD4(+) T-cells increase the antibody response to Env by intrastructural help
por: Nabi, Ghulam, et al.
Publicado: (2013)

Gag-Pol Processing during HIV-1 Virion Maturation: A Systems Biology Approach
por: Könnyű, Balázs, et al.
Publicado: (2013)

cis acting RNA sequences control the gag-pol translation readthrough in murine leukemia virus
por: Honigman, Alik, et al.
Publicado: (1991)

Mouse APOBEC3 interferes with autocatalytic cleavage of murine leukemia virus Pr180gag-pol precursor and inhibits Pr65gag processing
por: Hakata, Yoshiyuki, et al.
Publicado: (2019)

P20-18. Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes
por: Côrtes, FH, et al.
Publicado: (2009)

Effect of ART on poly functional profile of CD8 responses to Gag and Nef antigen in HIV infected Indian individuals
por: Mendiratta, Sanjay, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vpeqmoj1df2rbagbv4ku11kdvm